Moxifloxacin — Class II drug recall D-0288-2022
Terminated recall by Denver Solutions, LLC DBA Leiters Health, reported 2021-12-29, distributed nationwide. Labeling: Label Mix-up: Vials labeled as moxifloxacin 1 mg/mL may actually contain moxifloxacin 5 mg/mL
| Recall number | D-0288-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Denver Solutions, LLC DBA Leiters Health, Englewood, CO, United States |
| Recall initiated | 2021-11-29 |
| Classified | 2021-12-17 |
| Reported by FDA | 2021-12-29 |
| Terminated | 2022-07-12 |
| Distributed | Nationwide (US) |
| Quantity | 1,440 vials |
| Reason classes | labeling |
| NDC | 71449-0096-42 |
| Lot numbers | 2130958 |
| Expiration dates | 2022-03-31 |
Product
Moxifloxacin, 1 mg/mL, 1mL in 2mL vial, solution for intracameral injection, 10 vials/carton, Rx only, Leiters 13796 Compark Blvd, Englewood, CO 80112, (800) 292-6772, NDC 71449-096-42
Reason for recall
Labeling: Label Mix-up: Vials labeled as moxifloxacin 1 mg/mL may actually contain moxifloxacin 5 mg/mL
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0288-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.